178 related articles for article (PubMed ID: 17880502)
1. Study of protoporphyrin IX (PpIX) pharmacokinetics after topical application of 5-aminolevulinic acid in urethral condylomata acuminata.
Wang XL; Wang HW; Huang Z; Stepp H; Baumgartner R; Dannecker C; Hillemanns P
Photochem Photobiol; 2007; 83(5):1069-73. PubMed ID: 17880502
[TBL] [Abstract][Full Text] [Related]
2. In vivo fluorescence kinetics and photodynamic therapy in condylomata acuminata.
Stefanaki IM; Georgiou S; Themelis GC; Vazgiouraki EM; Tosca AD
Br J Dermatol; 2003 Nov; 149(5):972-6. PubMed ID: 14632801
[TBL] [Abstract][Full Text] [Related]
3. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment.
Ross EV; Romero R; Kollias N; Crum C; Anderson RR
Br J Dermatol; 1997 Nov; 137(5):736-42. PubMed ID: 9415233
[TBL] [Abstract][Full Text] [Related]
4. Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata.
Wang XL; Wang HW; Wang HS; Xu SZ; Liao KH; Hillemanns P
Br J Dermatol; 2004 Oct; 151(4):880-5. PubMed ID: 15491431
[TBL] [Abstract][Full Text] [Related]
5. Topical photodynamic therapy with 5-aminolaevulinic acid for condylomata acuminata on the distal urethra.
Sun Y; Ma YP; Wu Y; Liu J; Hong YX; Chen HD; Gao XH
Clin Exp Dermatol; 2012 Apr; 37(3):302-3. PubMed ID: 22409524
[No Abstract] [Full Text] [Related]
6. An open uncontrolled trial of topical 5-aminolevulinic acid photodynamic therapy for the treatment of urethral condylomata acuminata in male patients.
Shan X; Wang N; Li Z; Hou J; Zheng R; Tian H; Zhang F
Indian J Dermatol Venereol Leprol; 2016; 82(1):65-7. PubMed ID: 26728814
[No Abstract] [Full Text] [Related]
7. Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum.
van den Akker JT; Iani V; Star WM; Sterenborg HJ; Moan J
Photochem Photobiol; 2000 Nov; 72(5):681-9. PubMed ID: 11107855
[TBL] [Abstract][Full Text] [Related]
8. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study.
Lange N; Jichlinski P; Zellweger M; Forrer M; Marti A; Guillou L; Kucera P; Wagnières G; van den Bergh H
Br J Cancer; 1999 Apr; 80(1-2):185-93. PubMed ID: 10389995
[TBL] [Abstract][Full Text] [Related]
9. [Three stages of 5-aminolevulinic acid-photodynamic therapy for condyloma acuminatum of external urethral meatus].
Li J; Yi Y; Zhu W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1115-9. PubMed ID: 22169724
[TBL] [Abstract][Full Text] [Related]
10. The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of delta-aminolevulinic acid.
Calin MA; Gruia Ml; Herascu N; Coman T
J Exp Ther Oncol; 2004 Oct; 4(3):247-51. PubMed ID: 15724844
[TBL] [Abstract][Full Text] [Related]
11. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses.
Fauteck JD; Ackermann G; Birkel M; Breuer M; Moor AC; Ebeling A; Ortland C
Arch Dermatol Res; 2008 Feb; 300(2):53-60. PubMed ID: 17960406
[TBL] [Abstract][Full Text] [Related]
13. Protoporphyrin IX fluorescence and photobleaching during interstitial photodynamic therapy of malignant gliomas for early treatment prognosis.
Johansson A; Faber F; Kniebühler G; Stepp H; Sroka R; Egensperger R; Beyer W; Kreth FW
Lasers Surg Med; 2013 Apr; 45(4):225-34. PubMed ID: 23533060
[TBL] [Abstract][Full Text] [Related]
14. In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation.
Tsai JC; Chen IH; Wong TW; Lo YL
Br J Dermatol; 2002 May; 146(5):853-62. PubMed ID: 12000384
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of photodynamic therapy vs CO2 laser vaporization in treatment of condylomata acuminata: a randomized clinical trial.
Chen K; Chang BZ; Ju M; Zhang XH; Gu H
Br J Dermatol; 2007 Mar; 156(3):516-20. PubMed ID: 17300242
[TBL] [Abstract][Full Text] [Related]
16. 5-aminolevulinic acid photodynamic therapy combined with wart curettage treatment for intractable urethral condylomata acuminata. A case report.
Chang R; Zhang Y; Liu Y; Jiang F; Zhang S; Zhang C
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103264. PubMed ID: 36587864
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of condylomata acuminata of the urethra after conventional and fluorescence-controlled Nd:YAG laser treatment.
Zaak D; Hofstetter A; Frimberger D; Schneede P
Urology; 2003 May; 61(5):1011-5. PubMed ID: 12736026
[TBL] [Abstract][Full Text] [Related]
18. Treatment of anogenital condylomata acuminata with topical photodynamic therapy: report of 14 cases and review.
Nucci V; Torchia D; Cappugi P
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e280-2. PubMed ID: 20346722
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo.
Gerscher S; Connelly JP; Griffiths J; Brown SB; MacRobert AJ; Wong G; Rhodes LE
Photochem Photobiol; 2000 Oct; 72(4):569-74. PubMed ID: 11045731
[TBL] [Abstract][Full Text] [Related]
20. Systemic component of protoporphyrin IX production in nude mouse skin upon topical application of aminolevulinic acid depends on the application conditions.
van den Akker JT; Iani V; Star WM; Sterenborg HJ; Moan J
Photochem Photobiol; 2002 Feb; 75(2):172-7. PubMed ID: 11885562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
